Novartis—A Leader in Cancer Care
Novartis is a world leader in oncology; our mission is to consistently discover, develop, and produce broadly available novel therapies that improve and extend the lives of patients with cancer.
At Novartis, active basic and clinical research programs ensure that optimal cancer treatments continue to evolve. We use state-of-the-art technology to identify the best oncology compounds to hit specific molecular targets accurately and effectively. These laboratory lessons and clinical observations help refine and innovate basic research hypotheses.
Novartis—Clinical Trials
At Novartis, we are committed to improving the lives of patients with cancer. As part of this commitment, Novartis regularly conducts clinical trials to explore new approaches and to seek new solutions to today's challenging oncology questions. The success of such clinical trials depends upon the participation of patient volunteers.
Patients who participate in oncology clinical trials, such as the ATTRACT studies, gain access to new investigational treatments before they are widely available. More importantly, these patients contribute to significant medical research that may not merely benefit themselves but may benefit many others.
|
